Pre-Commercial Launch Readiness: Building the Data Foundation from Phase III to Launch 

Commercial success starts long before approval. The decisions you make about data, targeting and infrastructure in Phase III shape how effectively your team executes at launch and through every quarter that follows. 

Our guide walks through how Life Sciences organizations preparing for their first commercial launch can build a scalable, compliant data foundation that supports targeting, field execution and reporting from Phase III through launch and beyond. 

Download the Guide

Trusted by 800+ Life Sciences organizations, from emerging biotech to 9 of the top 10 pharmaceutical manufacturers. 

What’s Inside

From building your data foundation to operationalizing it in the field, our guide covers the strategic and operational decisions that shape a confident commercial launch.

  • The downstream cost of incomplete or non-authoritative data pre-launch, and the rework scenarios it creates after approval
  • A phase-by-phase framework for launch readiness, covering late Phase III, pre-NDA/BLA submission, NDA/BLA review, pre-launch and post-launch
  • The key components of a scalable, compliant commercial data foundation built for integration into your CRM, MDM and reporting systems
  • How pre-commercial organizations are approaching commercial target analysis, partner selection and field readiness ahead of first launch

About the Pre-Commercial Data Package

Built for emerging Life Sciences manufacturers, MedPro’s Pre-Commercial Data Package gives early-stage organizations access to the same industry-leading data foundation trusted by 800+ Life Sciences companies, with reduced upfront commitment and the flexibility to scale as your launch approaches.

  • Authoritative Sourcing: Data collected directly from verified state, federal and industry sources across all 50 states, including SLN, NPI, PECOS, AMA and NCPDP
  • Continuously Maintained Records: 5-10 million SLN acquisitions per week, with pre- and post-expiration checks to keep records current through launch and beyond
  • Built for Your Systems: Connects directly to CRM, MDM and T&E platforms through 20+ pre-built integrations, including Salesforce, Snowflake, Reltio and Informatica
  • Designed for Pre-Commercial Scale: A flexible access model built around pre-commercial needs, with a clear path into the full MedProID platform as your team grows
total records across all sources
lifetime SLN records acquired
of compliance expertise built into every program we support

See What You’re Missing Before Launch

Pair our guide with a complimentary Commercial Target Analysis . Our team will review your existing target list, surface data gaps and risks across your HCP universe and provide recommendations to strengthen targeting ahead of launch.

Data quality assessment of your existing target list

Key findings on gaps, inconsistencies and risks

Recommendations to refine targeting and improve launch readiness

Request Your Target Analysis

Frequently Asked Questions

This guide is built for commercial, operations and compliance leaders at pre-commercial Life Sciences organizations preparing for their first launch. Whether you are in late Phase III, approaching NDA submission or actively planning pre-launch execution, this resource walks through the data, system and partner decisions that shape a confident launch.

The Pre-Commercial Data Package is MedPro’s access model built for emerging Life Sciences manufacturers. It gives pre-commercial organizations access to MedPro’s industry-leading data foundation with reduced upfront commitment, designed to support targeting, field readiness and compliance from Phase III through launch.

Most organizations benefit from beginning data and partner evaluation 12 to 24 months pre-launch, in late Phase III. Building the foundation early supports cleaner target identification, smoother system integrations and a more coordinated launch, and helps avoid the rework that comes from compressing data decisions into the final months before approval.

A Commercial Target Analysis is a complimentary review of your existing target list. Our team assesses data quality, identifies gaps and risks in the records and provides recommendations to strengthen targeting ahead of launch. It is offered at no cost to pre-commercial Life Sciences organizations preparing for first launch.

Download the Guide

Complete the form for instant access to our pre-commercial launch readiness guide.

Request a Copy